Is a complete ATYR research report available?

No complete published report is available for aTyr Pharma, Inc. (ATYR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

aTyr Pharma, Inc. (ATYR)

NASDAQ: ATYR · USD

$0.13

+0.00 (+2.0%)· Recorded snapshot

Market cap	12.4M
Revenue (ttm)	190K
Net income (ttm)	-60.8M
EPS (ttm)	-$0.62
Shares out	98.1M
Volume	3,341,607
Beta	0.91

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 190K
Net income (ttm): -60.8M
EPS (ttm): -$0.62
Market cap: 12.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001339970
Company name	aTyr Pharma, Inc.
Country	United States
Country code	US
CUSIP number	002120202
Earnings date	2026-11-09
Earnings time	amc
Employees	60
Employees change	1
Employees growth	1.69%
Enterprise value	$-33.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
Industry	Biotechnology
IPO date	2015-05-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US0021202025
Last 10-K release date	2026-03-05
Last earnings date	2026-08-07
Last refreshed	2026-10-28
Last stock split date	2019-07-01
Last stock split type	Reverse
Market cap	$12.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.13
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	ATYR
U.S. state	California
Website	https://atyrpharma.com

Metric

Value

Amount currency

USD

CIK code

0001339970

Company name

aTyr Pharma, Inc.

Country

United States

Country code

CUSIP number

002120202

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

1.69%

Enterprise value

$-33.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

Industry

Biotechnology

IPO date

2015-05-07

Is primary listing

Yes

Is SPAC

ISIN number

US0021202025

Last 10-K release date

2026-03-05

Last earnings date

2026-08-07

Last refreshed

2026-10-28

Last stock split date

2019-07-01

Last stock split type

Reverse

Market cap

$12.4M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.13

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

ATYR

U.S. state

California

Website

https://atyrpharma.com

Metric	Value
Earnings yield	-491.21%
FCF / EV yield	163.23%
FCF yield	-437.31%
P/B ratio	0.25x
P/S ratio	65.98x
Price / tangible book value	0.26x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-491.21%

FCF / EV yield

163.23%

FCF yield

-437.31%

P/B ratio

0.25x

P/S ratio

65.98x

Price / tangible book value

0.26x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-33,609.47%
Pretax margin	-32,006.32%
Profit per employee	$-1M
Revenue per employee	$3,167
ROA	-46.58%
ROA (5Y)	-35.38%
ROCE	-109.29%
ROE	-98.68%
ROE (5Y)	-69.72%
ROIC	-54.22%
SBC / revenue	2,613.68%

Metric

Value

Operating margin

-33,609.47%

Pretax margin

-32,006.32%

Profit per employee

$-1M

Revenue per employee

$3,167

ROA

-46.58%

ROA (5Y)

-35.38%

ROCE

-109.29%

ROE

-98.68%

ROE (5Y)

-69.72%

ROIC

-54.22%

SBC / revenue

2,613.68%

Metric	Value
EPS growth quarters	3
EPS growth years	4
Net income growth quarters	3
Net income growth years	0
Revenue growth	-19.15%
Revenue growth 3Y	-73.65%
Revenue growth 5Y	-38.73%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-19.15%

Revenue growth 3Y

-73.65%

Revenue growth 5Y

-38.73%

Revenue growth years

Metric	Value
Capital expenditures	$-279,000
Depreciation and amortization	$661,000
EBIT	$-63.9M
EBITDA	$-63.2M
EPS	$-0.62
FCF per share	$-0.56
Financing cash flow	$29.2M
Free cash flow	$-54.8M
Free cash flow minus SBC	$-59.8M
Gross profit	$-46.9M
Investing cash flow	$22.9M
Net borrowing	$-562,000
Net cash flow	$-2.4M
Net income	$-60.8M
Operating cash flow minus SBC	$-59.5M
Operating income	$-63.9M
Revenue	$190,000
Stock-based compensation	$5M

Metric

Value

Capital expenditures

$-279,000

Depreciation and amortization

$661,000

EBIT

$-63.9M

EBITDA

$-63.2M

EPS

$-0.62

FCF per share

$-0.56

Financing cash flow

$29.2M

Free cash flow

$-54.8M

Free cash flow minus SBC

$-59.8M

Gross profit

$-46.9M

Investing cash flow

$22.9M

Net borrowing

$-562,000

Net cash flow

$-2.4M

Net income

$-60.8M

Operating cash flow minus SBC

$-59.5M

Operating income

$-63.9M

Revenue

$190,000

Stock-based compensation

$5M

Metric	Value
Altman Z-Score	-10.13
Book value per share	$0.50
Debt / equity	0.23
Long-term assets	$11.5M
Long-term liabilities	$9.8M
Net cash (debt)	$46.1M
Net cash / market cap	367.91%
Net cash growth	-31.85%
Net debt / equity	-0.95
Piotroski F-Score	1
Property, plant and equipment	$9.8M
Shareholders' equity	$48.6M
Tangible book value	$48.8M
Tangible book value per share	$0.50
Total assets	$69.8M
Total cash	$57.4M
Total debt	$11.3M
Total liabilities	$21.2M
WACC	4.88%

Metric

Value

Altman Z-Score

-10.13

Book value per share

$0.50

Debt / equity

0.23

Long-term assets

$11.5M

Long-term liabilities

$9.8M

Net cash (debt)

$46.1M

Net cash / market cap

367.91%

Net cash growth

-31.85%

Net debt / equity

-0.95

Piotroski F-Score

Property, plant and equipment

$9.8M

Shareholders' equity

$48.6M

Tangible book value

$48.8M

Tangible book value per share

$0.50

Total assets

$69.8M

Total cash

$57.4M

Total debt

$11.3M

Total liabilities

$21.2M

WACC

4.88%

Metric	Value
Asset turnover	0
Current assets	$58.4M
Current liabilities	$11.4M
Current ratio	5.12
Net working capital	$-9M
Quick ratio	5.08
Working capital	$47M
Working capital turnover	0

Metric

Value

Asset turnover

Current assets

$58.4M

Current liabilities

$11.4M

Current ratio

5.12

Net working capital

$-9M

Quick ratio

5.08

Working capital

$47M

Working capital turnover

Metric	Value
Buyback yield / dilution	-16.75%
Dividend yield	0%
Shareholder yield	-16.75%

Metric

Value

Buyback yield / dilution

-16.75%

Dividend yield

Shareholder yield

-16.75%

Metric	Value
10Y price change	-99.7%
10Y return CAGR	-43.98%
10Y total return	-99.7%
150-day SMA	$0.53
1D price change	2.02%
1M price change	-59.44%
1M total return	-59.44%
1W price change	-28.62%
1W total return	-28.62%
1Y price change	-87.29%
1Y return CAGR	-87.31%
1Y total return	-87.29%
20-day SMA	$0.21
200-day SMA	$0.61
3M price change	-74.73%
3M total return	-74.73%
3Y price change	-89.69%
3Y return CAGR	-53.1%
3Y total return	-89.69%
50-day SMA	$0.35
50-day SMA vs 200-day SMA	50under200
52-week high	$1.11
52-week high date	2026-02-19
52-week low	$0.10
52-week low date	2026-10-27
5Y price change	-98.57%
5Y return CAGR	-57.23%
5Y total return	-98.57%
6M price change	-84.36%
6M total return	-84.36%
All-time high	$396.06
All-time high date	2015-06-04
All-time low	$0.10
All-time low date	2026-10-27
Average true range (ATR)	$0.02
Average volume	2.2M
Beta (1Y)	2.74
Beta (2Y)	1.36
Beta (5Y)	0.91
Change from 52-week high	-88.6%
Change from 52-week low	24.39%
Change from all-time high	-99.97%
Change from all-time low	21.63%
Change from open	5.24%
Day's gap	-3.06%
Dollar volume	$422,713
High price	$0.13
Low price	$0.12
Monthly RSI	34.28
Open price	$0.12
Position in 52-week range	75.78%
Premarket change	-0.08%
Premarket close	$0.12
Premarket price	$0.12
Premarket volume	61.4K
Previous close	$0.12
Price vs 150-day SMA	-76.44%
Price vs 20-day SMA	-40.33%
Price vs 200-day SMA	-79.74%
Price vs 50-day SMA	-64.22%
Relative volume	1.5
RSI	10.57
Sharpe ratio	-1.37
Sharpe ratio (3Y)	-0.09
Sharpe ratio (5Y)	-0.47
Sortino ratio	-1.84
Sortino ratio (3Y)	-0.06
Sortino ratio (5Y)	-0.57
Volume	3.3M
Weekly RSI	26.49
YTD price change	-84.2%
YTD total return	-84.2%

Metric

Value

10Y price change

-99.7%

10Y return CAGR

-43.98%

10Y total return

-99.7%

150-day SMA

$0.53

1D price change

2.02%

1M price change

-59.44%

1M total return

-59.44%

1W price change

-28.62%

1W total return

-28.62%

1Y price change

-87.29%

1Y return CAGR

-87.31%

1Y total return

-87.29%

20-day SMA

$0.21

200-day SMA

$0.61

3M price change

-74.73%

3M total return

-74.73%

3Y price change

-89.69%

3Y return CAGR

-53.1%

3Y total return

-89.69%

50-day SMA

$0.35

50-day SMA vs 200-day SMA

50under200

52-week high

$1.11

52-week high date

2026-02-19

52-week low

$0.10

52-week low date

2026-10-27

5Y price change

-98.57%

5Y return CAGR

-57.23%

5Y total return

-98.57%

6M price change

-84.36%

6M total return

-84.36%

All-time high

$396.06

All-time high date

2015-06-04

All-time low

$0.10

All-time low date

2026-10-27

Average true range (ATR)

$0.02

Average volume

2.2M

Beta (1Y)

2.74

Beta (2Y)

1.36

Beta (5Y)

0.91

Change from 52-week high

-88.6%

Change from 52-week low

24.39%

Change from all-time high

-99.97%

Change from all-time low

21.63%

Change from open

5.24%

Day's gap

-3.06%

Dollar volume

$422,713

High price

$0.13

Low price

$0.12

Monthly RSI

34.28

Open price

$0.12

Position in 52-week range

75.78%

Premarket change

-0.08%

Premarket close

$0.12

Premarket price

$0.12

Premarket volume

61.4K

Previous close

$0.12

Price vs 150-day SMA

-76.44%

Price vs 20-day SMA

-40.33%

Price vs 200-day SMA

-79.74%

Price vs 50-day SMA

-64.22%

Relative volume

1.5

RSI

10.57

Sharpe ratio

-1.37

Sharpe ratio (3Y)

-0.09

Sharpe ratio (5Y)

-0.47

Sortino ratio

-1.84

Sortino ratio (3Y)

-0.06

Sortino ratio (5Y)

-0.57

Volume

3.3M

Weekly RSI

26.49

YTD price change

-84.2%

YTD total return

-84.2%

Metric	Value
Float	97.7M
Float percentage	99.65%
Shares change (QoQ)	0.03%
Shares change (YoY)	16.75%
Shares held by insiders	0.35%
Shares held by institutions	35.97%
Shares outstanding	98.1M
Short % of float	13.19%
Short % of shares	13.14%
Short ratio	1.7 days

Metric

Value

Float

97.7M

Float percentage

99.65%

Shares change (QoQ)

0.03%

Shares change (YoY)

16.75%

Shares held by insiders

0.35%

Shares held by institutions

35.97%

Shares outstanding

98.1M

Short % of float

13.19%

Short % of shares

13.14%

Short ratio

1.7 days

aTyr Pharma, Inc. (ATYR)

Price

Financial snapshot

Fair-value bridge

Latest news · ATYR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ATYR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ATYR

Frequently asked questions